Spyre Therapeutics, Inc. (SYRE) Earnings
NASDAQ·Healthcare·Biotechnology
$105.59
+1.67%
Mkt Cap $9.59B
EPS — Estimate vs Actual
Mkt Cap
$9.59B
P/E
—
Fwd P/E
—
P/S
98.48
Rev TTM
—
EPS TTM
-$2.19
NASDAQ·Healthcare·Biotechnology
$105.59
+1.67%
Mkt Cap $9.59B
Mkt Cap
$9.59B
P/E
—
Fwd P/E
—
P/S
98.48
Rev TTM
—
EPS TTM
-$2.19